The inhibitory efect of Phα1β toxin on diabetic neuropathic pain involves the CXCR4 chemokine receptor.

Simple item page
dc.contributor.authorSilva Júnior, Cláudio Antônio da
dc.contributor.authorCastro Junior, Célio José de
dc.contributor.authorPereira, Elizete Maria Rita
dc.contributor.authorBinda, Nancy Scardua
dc.contributor.authorSilva, Juliana Figueira da
dc.contributor.authorCordeiro, Marta do Nascimento
dc.contributor.authorDiniz, Danuza Montijo
dc.contributor.authorSanta Cecília, Flávia Viana
dc.contributor.authorFerreira, Juliano
dc.contributor.authorGomez, Marcus Vinicius
dc.date.accessioned2020-05-22T16:33:56Z
dc.date.available2020-05-22T16:33:56Z
dc.date.issued2020
dc.description.abstractBackground: Diabetic neuropathy is a common cause of painful diabetic neuropathy (PDN). C-X-C chemokine receptor type 4 (CXCR4) expression is increased in peripheral nerve samples from diabetes patients, suggesting a role for CXCR4 in PDN. Therefore, we evaluated the effects of Phα1β, ω-conotoxin MVIIA, and AMD3100 in a model of streptozotocin (STZ)-induced PDN in rodents and naïve model of rats with the activation of the CXCR4/stromal cell-derived factor 1 (SDF-1) signal. Methods: Diabetic neuropathy was induced by intraperitoneal (ip) injection of STZ in Wistar rats. Naïve rats were intrathecally injected with SDF-1 to test the CXCR4/SDF-1 signal. The effects of Phα1β intrathecal (it), ω-conotoxin MVIIA intrathecal (it), and AMD3100 intraperitoneal (ip) on rat hypersensitivity, IL-6, and the intracellular calcium [Ca2+]i content of diabetic synaptosomes were studied. Results: The drugs reduced the hypersensitivity in diabetic rats. SDF-1 (1.0 µg/it) administration in naïve rats induced hypersensitivity. Phα1β (100 pmol/it) or AMD3100 (2.5 µg/ip) reduced this hypersensitivity after 2 h treatments, while ω-conotoxin MVIIA did not have an effect. IL-6 and [Ca2+]i content increased in the spinal cord synaptosomes in diabetic rats. The drug treatments reduced IL-6 and the calcium influx in diabetic synaptosomes. Conclusions: Phα1β, ω-conotoxin MVIIA, and AMD3100, after 2 h of treatment of STZ-induced PDN, reduced hypersensitivity in diabetic rats. In naïve rats with CXCR4/SDF-1 activation, the induced hypersensitivity decreased after 2 h treatments with Phα1β or AMD-3100, while ω-conotoxin MVIIA did not affect. The inhibitory effects of Phα1β on PDN may involve voltage-dependent calcium channels.pt_BR
dc.identifier.citationSILVA JÚNIOR, C. A. et al. The inhibitory efect of Phα1β toxin on diabetic neuropathic pain involves the CXCR4 chemokine receptor. Pharmacological Reports, v. 72, p. 47–54, jan. 2020. Disponível em: <https://link.springer.com/article/10.1007/s43440-019-00002-3>. Acesso em: 10 fev. 2020.pt_BR
dc.identifier.doihttps://doi.org/10.1007/s43440-019-00002-3pt_BR
dc.identifier.issn2299-5684
dc.identifier.urihttp://www.repositorio.ufop.br/handle/123456789/12244
dc.identifier.uri2https://link.springer.com/article/10.1007/s43440-019-00002-3pt_BR
dc.language.isoen_USpt_BR
dc.rightsrestritopt_BR
dc.subjectω-Conotoxin MVIIApt_BR
dc.titleThe inhibitory efect of Phα1β toxin on diabetic neuropathic pain involves the CXCR4 chemokine receptor.pt_BR
dc.typeArtigo publicado em periodicopt_BR
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ARTIGO_InhibitoryEffectToxin.pdf
Size:
922.93 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
924 B
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
DEFAR - Artigos publicados em periódicos